In molecular genomics and oncology, we spent much of last year developing and validating our Haystack MRD blood test to aid in the ... provide results through our MyQuest application, and our ...

Attomarker insists the test can help many long Covid patients, should it be rolled out in the future An Exeter-based research firm has developed what it believes is a "world first" breakthrough ...

New research has confirmed a common-sense conclusion — with some important takeaways. People with a more positive outlook on life came through the COVID pandemic better than others did ...

An Exeter-based research firm has developed what it believes is a "world first" breakthrough test to help confirm the existence of long Covid in some patients. Attomarker, which specialises in ...

What to do if you test positive for flu If you have symptoms but test negative for flu or Covid, you could have a different ...

NEW YORK, Jan 25 (Reuters) - The Central Intelligence Agency has assessed that the COVID-19 pandemic is more likely to have emerged from a lab than from nature, an agency spokesperson said on ...

A study suggests that catching COVID-19 significantly raises the risk of developing ME/CFS (formerly called "chronic fatigue syndrome"), a typically lifelong condition that can be debilitating.

But the vaccine can lower your risk of serious infection, hospitalization, or death from COVID. Can pets get COVID? Some pets have tested positive for ... and there's no test for it, it can ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. In a small study, patients with the syndrome were ...

As COVID-19 began to surge five years ago, no one knew what to expect. Neither did the immune system. Confronted with a new virus, humanity was immunologically naive. The emergence of SARS-CoV-2 ...

Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: Who will pay for drug development and trials? The Senate on Thursday ...